Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Chemistry of biologically important synthetic organoselenium compounds
The element selenium was discovered in 1818 by the Swedish chemist Berzelius and was
named after the Greek goddess of the moon, Selene. 1 In biology, selenium was long …
named after the Greek goddess of the moon, Selene. 1 In biology, selenium was long …
Apoptosis is a critical cellular event in cancer chemoprevention and chemotherapy by selenium compounds
R Sinha, K El-Bayoumy - Current cancer drug targets, 2004 - benthamdirect.com
Epidemiological studies, preclinical investigations and clinical intervention trials support the
role of selenium compounds as potent cancer chemopreventive agents; the dose and the …
role of selenium compounds as potent cancer chemopreventive agents; the dose and the …
Crystal structure of the atypical protein kinase domain of a TRP channel with phosphotransferase activity
Transient receptor potential (TRP) channels modulate calcium levels in eukaryotic cells in
response to external signals. A novel transient receptor potential channel has the ability to …
response to external signals. A novel transient receptor potential channel has the ability to …
Organoselenium compounds as potential therapeutic and chemopreventive agents: a review
M Soriano-Garcia - Current medicinal chemistry, 2004 - benthamdirect.com
Selenium is an essential trace element. It is, however toxic at concentration little above
which is required for health. Selenium is incorporated into proteins as selenocysteine, the …
which is required for health. Selenium is incorporated into proteins as selenocysteine, the …
Biologically significant selenium-containing heterocycles
M Ninomiya, DR Garud, M Koketsu - Coordination Chemistry Reviews, 2011 - Elsevier
Selenium represents an essential element for organisms as various diseases can result from
selenium deficiency. As a consequence, selenium-containing heterocycles are of …
selenium deficiency. As a consequence, selenium-containing heterocycles are of …
Eukaryotic elongation factor 2 kinase as a drug target in cancer, and in cardiovascular and neurodegenerative diseases
Eukaryotic elongation factor 2 kinase (eEF2K) is an unusual protein kinase that regulates
the elongation stage of protein synthesis by phosphorylating and inhibiting its only known …
the elongation stage of protein synthesis by phosphorylating and inhibiting its only known …
1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) induces phosphorylation of eukaryotic elongation factor-2 (eEF2): a cautionary note on the anticancer …
Z Chen, SM Gopalakrishnan, MH Bui, NB Soni… - Journal of Biological …, 2011 - jbc.org
Eukaryotic elongation factor-2 kinase (eEF2K) relays growth and stress signals to protein
synthesis through phosphorylation and inactivation of eukaryotic elongation factor 2 (eEF2) …
synthesis through phosphorylation and inactivation of eukaryotic elongation factor 2 (eEF2) …
Reaction of lithium aluminum hydride with elemental selenium: Its application as a selenating reagent into organic molecules
H Ishihara, M Koketsu, Y Fukuta… - Journal of the American …, 2001 - ACS Publications
Recently many syntheses of compounds containing selenium have been studied and
reported because of the interesting reactivities1 and their potential pharmaceutical …
reported because of the interesting reactivities1 and their potential pharmaceutical …
Identification and characterization of an inhibitor of eukaryotic elongation factor 2 kinase against human cancer cell lines
S Arora, JM Yang, TG Kinzy, R Utsumi… - Cancer …, 2003 - aacrjournals.org
Recent evidence suggests that the machinery of protein synthesis may provide novel targets
for anticancer drugs. For example, aberrations in protein synthesis are commonly …
for anticancer drugs. For example, aberrations in protein synthesis are commonly …
Eukaryotic elongation factor-2 kinase (eEF2K) signaling in tumor and microenvironment as a novel molecular target
Eukaryotic elongation factor-2 kinase (eEF2K), an atypical member of alpha-kinase family, is
highly overexpressed in breast, pancreatic, brain, and lung cancers, and associated with …
highly overexpressed in breast, pancreatic, brain, and lung cancers, and associated with …